Emily English - Apr 15, 2025 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role: Chief Operations Officer
Signature: /s/ Matthew Bartholomae, Attorney-in-Fact for Emily English
Stock symbol: RNAC
Transactions as of: Apr 15, 2025
Transactions value $: $24,750
Form type: 4
Date filed: 4/16/2025, 04:35 PM
Previous filing: Jan 7, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RNAC	Common Stock	Options Exercise	$24.8K	+7.5K	+18.64%	$3.30	47.7K	Apr 15, 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RNAC	Stock Option (Right to Buy)	Options Exercise		-7.5K	-15.19%		41.9K	Apr 15, 2025	Common Stock	7.5K	$3.30	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options are currently fully vested and exercisable.
F2	On November 13, 2023, the issuer acquired the Delaware corporation which was then-known as Cartesian Therapeutics, Inc. ("Old Cartesian") in accordance with the terms of an Agreement and Plan of Merger, dated November 13, 2023. Options to purchase Old Cartesian common stock held by the reporting person were converted into options to purchase shares of the issuer's common stock in connection with the merger.

Content

These options are currently fully vested and exercisable.

On November 13, 2023, the issuer acquired the Delaware corporation which was then-known as Cartesian Therapeutics, Inc. ("Old Cartesian") in accordance with the terms of an Agreement and Plan of Merger, dated November 13, 2023. Options to purchase Old Cartesian common stock held by the reporting person were converted into options to purchase shares of the issuer's common stock in connection with the merger.